A61K 9/2813
Inorganic compounds
Official title: {Inorganic compounds}
A61K9/2813 (Inorganic compounds) appears on 317 US grants and 609 published applications in this corpus.
Search patents in A61K- Granted patents
- 317
- Published applications
- 609
- Assignees
- 251
- Inventors
- 970
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 3 |
| 2002 | 5 | 1 |
| 2003 | 4 | 11 |
| 2004 | 3 | 16 |
| 2005 | 2 | 14 |
| 2006 | 3 | 12 |
| 2007 | 3 | 9 |
| 2008 | 5 | 13 |
| 2009 | 2 | 12 |
| 2010 | 2 | 10 |
| 2011 | 6 | 17 |
| 2012 | 13 | 30 |
| 2013 | 12 | 28 |
| 2014 | 16 | 26 |
| 2015 | 16 | 43 |
| 2016 | 19 | 58 |
| 2017 | 20 | 49 |
| 2018 | 32 | 24 |
| 2019 | 15 | 35 |
| 2020 | 22 | 29 |
| 2021 | 19 | 38 |
| 2022 | 13 | 28 |
| 2023 | 13 | 31 |
| 2024 | 12 | 26 |
| 2025 | 17 | 24 |
| 2026 | 13 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mixture of compounds with high molecular weights, obtained from sugar cane wax (Saccharum officinarum L.)11 Aug 2026US 12,703,836 B2Centro Nacional de Investigaciones Cientificas
- Coated solid preparation28 Jul 2026US 12,691,073 B2Towa Pharmaceutical Co., Ltd.
- Pharmaceutical composition14 Jul 2026US 12,678,426 B2Kowa Company, Ltd.
- DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation14 Jul 2026US 12,678,442 B2Boehringer Ingelheim International GmbH
- Substituted tetrazoles as ACSS2 inhibitors7 Jul 2026US 12,673,046 B2Merck Patent GmbH
- Methods of treating erythropoietic protoporphyria or x-linked protoporphyria with bitopertin1 Oct 2026US 2026/0294899 A1Disc Medicine, Inc.
- Tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)- n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide1 Oct 2026US 2026/0294904 A1Hoffmann-La Roche Inc.
- Controlled Release Formulations of Highly Lipophilic Physiologically Active Substances17 Sep 2026US 2026/0272955 A1ADD Advanced Drug Delivery Technologies Ltd.
- Formulations of (+)-2-[1-(3-ethoxy-4- methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione27 Aug 2026US 2026/0248727 A1Amgen Inc.
- Novel oral dosage form27 Aug 2026US 2026/0248729 A1Neon Healthcare Ltd
Most cited
By later US patents
- Pharmaceutical formulation containing gelling agent198US 8,337,888 B2Purdue Pharma L. P. · 2012
- Substituted benzimidazole dosage forms and method of using same159US 6,645,988 B2The Curators of the University of Missouri · 2003
- Membrane-coated sustained-release tablets and method151US 4,557,925 AAB Ferrosan · 1985
- Controlled release tablet formulation131US 5,458,887 AAndrx Pharmaceuticals, Inc. · 1995
- Substituted benzimidazole dosage forms and methods of using same104US 6,699,885 B2The Curators of the University of Missouri · 2004